BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20166942)

  • 1. Exploration of structure-activity relationships for dual serotonin transporter reuptake inhibitors-histamine H3 receptor antagonists.
    Stocking EM; Letavic MA; Bonaventure P; Carruthers NI
    Curr Top Med Chem; 2010; 10(5):596-616. PubMed ID: 20166942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of diamine-based histamine H3 antagonists with serotonin reuptake inhibitor activity.
    Stocking EM; Miller JM; Barbier AJ; Wilson SJ; Boggs JD; McAllister HM; Wu J; Lovenberg TW; Carruthers NI; Wolin RL
    Bioorg Med Chem Lett; 2007 Jun; 17(11):3130-5. PubMed ID: 17412583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel naphthyridines are histamine H3 antagonists and serotonin reuptake transporter inhibitors.
    Letavic MA; Keith JM; Ly KS; Barbier AJ; Boggs JD; Wilson SJ; Lord B; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2007 May; 17(9):2566-9. PubMed ID: 17307358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitors.
    Letavic MA; Keith JM; Jablonowski JA; Stocking EM; Gomez LA; Ly KS; Miller JM; Barbier AJ; Bonaventure P; Boggs JD; Wilson SJ; Miller KL; Lord B; McAllister HM; Tognarelli DJ; Wu J; Abad MC; Schubert C; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2007 Feb; 17(4):1047-51. PubMed ID: 17127059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.
    Letavic MA; Stocking EM; Barbier AJ; Bonaventure P; Boggs JD; Lord B; Miller KL; Wilson SJ; Carruthers NI
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4799-803. PubMed ID: 17616397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrrolidino-tetrahydroisoquinolines as potent dual H3 antagonist and serotonin transporter inhibitors.
    Keith JM; Gomez LA; Wolin RL; Barbier AJ; Wilson SJ; Boggs JD; Mazur C; Fraser IC; Lord B; Aluisio L; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2007 May; 17(9):2603-7. PubMed ID: 17317177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of JNJ-28583867, a histamine H(3) receptor antagonist and serotonin reuptake inhibitor.
    Barbier AJ; Aluisio L; Lord B; Qu Y; Wilson SJ; Boggs JD; Bonaventure P; Miller K; Fraser I; Dvorak L; Pudiak C; Dugovic C; Shelton J; Mazur C; Letavic MA; Carruthers NI; Lovenberg TW
    Eur J Pharmacol; 2007 Dec; 576(1-3):43-54. PubMed ID: 17765221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a dual histamine H1/H3 receptor ligand based on the H1 antagonist chlorpheniramine.
    Aslanian R; Mutahi Mw; Shih NY; Piwinski JJ; West R; Williams SM; She S; Wu RL; Hey JA
    Bioorg Med Chem Lett; 2003 Jun; 13(12):1959-61. PubMed ID: 12781173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acidic elements in histamine H(3) receptor antagonists.
    Sander K; von Coburg Y; Camelin JC; Ligneau X; Rau O; Schubert-Zsilavecz M; Schwartz JC; Stark H
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1581-4. PubMed ID: 20138762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of histamine H
    Watanabe M; Kobayashi T; Ito Y; Fukuda H; Yamada S; Arisawa M; Shuto S
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3630-3633. PubMed ID: 30385161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First metal-containing histamine H3 receptor ligands.
    Sander K; Kottke T; Hoffend C; Walter M; Weizel L; Camelin JC; Ligneau X; Schneider EH; Seifert R; Schwartz JC; Stark H
    Org Lett; 2010 Jun; 12(11):2578-81. PubMed ID: 20446742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-activity relationships of non-imidazole H(3) receptor ligands. Part 3: 5-Substituted 3-phenyl-1,2,4-oxadiazoles as potent antagonists.
    Gfesser GA; Zhang H; Dinges J; Fox GB; Pan JB; Esbenshade TA; Yao BB; Witte D; Miller TR; Kang CH; Krueger KM; Bennani YL; Hancock AA; Faghih R
    Bioorg Med Chem Lett; 2004 Feb; 14(3):673-6. PubMed ID: 14741266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual serotonin transporter inhibitor/histamine H3 antagonists: development of rigidified H3 pharmacophores.
    Keith JM; Barbier AJ; Wilson SJ; Miller K; Boggs JD; Fraser IC; Mazur C; Lovenberg TW; Carruthers NI
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5325-9. PubMed ID: 17765543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of 4- and 5-pyridazin-3-one phenoxypropylamine analogues as histamine-3 receptor antagonists.
    Becknell NC; Lyons JA; Aimone LD; Huang Z; Gruner JA; Raddatz R; Hudkins RL
    Bioorg Med Chem; 2012 Jun; 20(12):3880-6. PubMed ID: 22578490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Potent and Selective Histamine H
    Hino N; Marumo T; Kotani M; Shimazaki T; Kaku-Fukumoto A; Hikichi H; Karasawa JI; Tomishima Y; Komiyama H; Tatsuda E; Nozawa D; Nakamura T; Chaki S
    J Pharmacol Exp Ther; 2020 Nov; 375(2):276-285. PubMed ID: 32862143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of FUB 181, a selective histamine H3-receptor antagonist of high oral in vivo potency with 4-(omega-(arylalkyloxy)alkyl)-1H-imidazole structure.
    Stark H; Hüls A; Ligneau X; Purand K; Pertz H; Arrang JM; Schwartz JC; Schunack W
    Arch Pharm (Weinheim); 1998 Jun; 331(6):211-8. PubMed ID: 9713254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicinal chemical and pharmacological aspects of imidazole-containing histamine H3 receptor antagonists.
    Stark H; Kathmann M; Schlicker E; Schunack W; Schlegel B; Sippl W
    Mini Rev Med Chem; 2004 Nov; 4(9):965-77. PubMed ID: 15544557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of disubstituted piperidines and homopiperidines as potent dual NK1 receptor antagonists-serotonin reuptake transporter inhibitors for the treatment of depression.
    Wu YJ; He H; Bertekap R; Westphal R; Lelas S; Newton A; Wallace T; Taber M; Davis C; Macor JE; Bronson J
    Bioorg Med Chem; 2013 Apr; 21(8):2217-2228. PubMed ID: 23477943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.
    Ly KS; Letavic MA; Keith JM; Miller JM; Stocking EM; Barbier AJ; Bonaventure P; Lord B; Jiang X; Boggs JD; Dvorak L; Miller KL; Nepomuceno D; Wilson SJ; Carruthers NI
    Bioorg Med Chem Lett; 2008 Jan; 18(1):39-43. PubMed ID: 18060777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medicinal chemistry and biological properties of non-imidazole histamine H3 antagonists.
    Cowart M; Altenbach R; Black L; Faghih R; Zhao C; Hancock AA
    Mini Rev Med Chem; 2004 Nov; 4(9):979-92. PubMed ID: 15544558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.